P Chavarot

767 total citations
13 papers, 649 citations indexed

About

P Chavarot is a scholar working on Infectious Diseases, Epidemiology and Immunology. According to data from OpenAlex, P Chavarot has authored 13 papers receiving a total of 649 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 8 papers in Epidemiology and 7 papers in Immunology. Recurrent topics in P Chavarot's work include Tuberculosis Research and Epidemiology (12 papers), Mycobacterium research and diagnosis (8 papers) and Immune Response and Inflammation (3 papers). P Chavarot is often cited by papers focused on Tuberculosis Research and Epidemiology (12 papers), Mycobacterium research and diagnosis (8 papers) and Immune Response and Inflammation (3 papers). P Chavarot collaborates with scholars based in France, United States and Belgium. P Chavarot's co-authors include G Marchal, M. Lagranderie, Danielle Ensergueix, Brigitte Gicquel, A.M. Balazuc, Françoise Thouron, Christophe Guilhot, Mary Jackson, David N. McMurray and Pierre Gounon and has published in prestigious journals such as Science, The Journal of Immunology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

P Chavarot

13 papers receiving 628 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
P Chavarot France	10	450	334	240	164	72	13	649
Niaz Banaiee United States	10	597 1.3×	456 1.4×	371 1.5×	167 1.0×	134 1.9×	11	891
Richard K. Groger United States	14	320 0.7×	443 1.3×	132 0.6×	247 1.5×	66 0.9×	18	839
S K Furney United States	12	613 1.4×	520 1.6×	272 1.1×	185 1.1×	116 1.6×	13	791
H Tasaka Japan	15	497 1.1×	497 1.5×	197 0.8×	208 1.3×	78 1.1×	48	873
Kamlesh Bhatt United States	14	547 1.2×	379 1.1×	318 1.3×	155 0.9×	86 1.2×	23	813
Sadhana Chitale United States	8	448 1.0×	362 1.1×	199 0.8×	167 1.0×	122 1.7×	12	679
Suraj B. Sable United States	17	423 0.9×	259 0.8×	317 1.3×	206 1.3×	65 0.9×	20	735
Marc A. Keen United States	10	528 1.2×	411 1.2×	452 1.9×	149 0.9×	108 1.5×	10	802
K. Edmonds United States	13	614 1.4×	599 1.8×	275 1.1×	129 0.8×	168 2.3×	16	1.1k
Candida Fratazzi United States	11	368 0.8×	315 0.9×	242 1.0×	219 1.3×	76 1.1×	28	727

Countries citing papers authored by P Chavarot

Since Specialization

Citations

This map shows the geographic impact of P Chavarot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Chavarot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Chavarot more than expected).

Fields of papers citing papers by P Chavarot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Chavarot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Chavarot. The network helps show where P Chavarot may publish in the future.

Co-authorship network of co-authors of P Chavarot

This figure shows the co-authorship network connecting the top 25 collaborators of P Chavarot. A scholar is included among the top collaborators of P Chavarot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Chavarot. P Chavarot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Munier‐Lehmann, Hélène, P. Hendrickx, G Marchal, et al.. (2006). Synthesis and Biological Evaluation of Bicyclic Nucleosides as Inhibitors of M. tuberculosis Thymidylate Kinase. ChemMedChem. 1(10). 1081–1090. 32 indexed citations

Chavarot, P, et al.. (2005). A nose-only apparatus for airborne delivery of Mycobacterium tuberculosis to mice: calibration of biological parameters. Microbes and Infection. 7(3). 457–466. 4 indexed citations

Balazuc, A.M., M. Lagranderie, P Chavarot, et al.. (2005). In vivo efficiency of targeted norfloxacin against persistent, isoniazid-insensitive, Mycobacterium bovis BCG present in the physiologically hypoxic mouse liver. Microbes and Infection. 7(7-8). 969–975. 11 indexed citations

Domurado, Dominique, A.M. Balazuc, M. Lagranderie, et al.. (2005). Targeted norfloxacin is active in vivo against persistent Mycobacterium bovis BCG.. PubMed. 101(1-3). 343–5. 3 indexed citations

Coessens, Veerle, Anne‐Marie Balazuc, M. Lagranderie, et al.. (2003). Synthesis, Degradation, and Antimicrobial Properties of Targeted Macromolecular Prodrugs of Norfloxacin. Antimicrobial Agents and Chemotherapy. 47(11). 3435–3441. 28 indexed citations

Lagranderie, M., A.M. Balazuc, P Chavarot, et al.. (2002). Development of Mixed Th1/Th2 Type Immune Response and Protection Against Mycobacterium tuberculosis After Rectal or Subcutaneous Immunization of Newborn and Adult Mice with Mycobacterium bovis BCG. Scandinavian Journal of Immunology. 55(3). 293–303. 27 indexed citations

Olleros, Maria L., Reto Guler, Nadia Corazza, et al.. (2002). Transmembrane TNF Induces an Efficient Cell-Mediated Immunity and Resistance to Mycobacterium bovis Bacillus Calmette-Guerin Infection in the Absence of Secreted TNF and Lymphotoxin-α. The Journal of Immunology. 168(7). 3394–3401. 98 indexed citations

Lagranderie, M., P Chavarot, A.M. Balazuc, & G Marchal. (2000). Immunogenicity and protective capacity of Mycobacterium bovis BCG after oral or intragastric administration in mice. Vaccine. 18(13). 1186–1195. 45 indexed citations

Lagranderie, M., et al.. (2000). Mycobacterium bovisBCG Induces Similar Immune Responses and Protection by Rectal and Parenteral Immunization Routes. Infection and Immunity. 68(10). 5657–5662. 33 indexed citations

10.

Jackson, Mary, M. Lagranderie, Danielle Ensergueix, et al.. (1999). Persistence and Protective Efficacy of a Mycobacterium tuberculosis Auxotroph Vaccine. Infection and Immunity. 67(6). 2867–2873. 143 indexed citations

11.

Lagranderie, M., Pierre Gounon, Christine Laurent‐Winter, et al.. (1998). Attenuation of Virulence by Disruption of the Mycobacterium tuberculosis erp Gene. Science. 282(5389). 759–762. 161 indexed citations

12.

Thierry, Dominique, P Chavarot, G Marchal, et al.. (1995). Mycobacterium tuberculosis strains unidentified using the IS6110 probe can be detected by oligonucleotides derived from the Mt308 sequence. Research in Microbiology. 146(4). 325–328. 9 indexed citations

13.

Félix, Romain, Pascale Pescher, P Chavarot, et al.. (1993). Identification of a Mycobacterium bovis BCG 45/47-kilodalton antigen complex, an immunodominant target for antibody response after immunization with living bacteria. Infection and Immunity. 61(2). 742–750. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact